{
  "id": "ba571bf3422d06e34fb5d204b72d0f8ac0bc25e5",
  "url": "https://www.r-bloggers.com/2023/11/exploring-pharmacokinetic-and-pharmacodynamic-drug-drug-interactions-with-our-drug-interactions-shiny-app/",
  "created_at_utc": "2025-11-17T20:39:21Z",
  "data": null,
  "raw_original": {
    "uuid": "8e02e1ea-e098-4517-b829-5aa1207e3a0a",
    "created_at": "2025-11-17 20:39:21",
    "raw_json": {
      "article_author": null,
      "article_headline": null,
      "article_modified": null,
      "article_published": null,
      "article_section": null,
      "article_tags": null,
      "canonical_url": "https://www.r-bloggers.com/2023/11/exploring-pharmacokinetic-and-pharmacodynamic-drug-drug-interactions-with-our-drug-interactions-shiny-app/",
      "crawled_at": "2025-11-17T09:59:42.261323",
      "external_links": [
        {
          "href": "https://appsilon.com/exploring-drug-interactions-shiny-app/",
          "text": "Tag: r - Appsilon | Enterprise R Shiny Dashboards"
        },
        {
          "href": "http://r-posts.com/",
          "text": "here"
        },
        {
          "href": "https://appsilon.com/drug-drug-interactions-r-shiny/",
          "text": "drug-drug interactions"
        },
        {
          "href": "https://demo.prod.appsilon.ai/drug-interaction/",
          "text": "drug interactions Shiny app."
        },
        {
          "href": "https://www.nlm.nih.gov/",
          "text": "US National Library of Medicine and the National Institute of Health"
        },
        {
          "href": "https://appsilon.com/exploring-drug-interactions-shiny-app/#introduction",
          "text": "What is a Drug Interaction?"
        },
        {
          "href": "https://appsilon.com/exploring-drug-interactions-shiny-app/#important",
          "text": "Important Note"
        },
        {
          "href": "https://appsilon.com/exploring-drug-interactions-shiny-app/#drug-interactions",
          "text": "What Kind of Drug Interactions Can Occur?"
        },
        {
          "href": "https://appsilon.com/exploring-drug-interactions-shiny-app/#quick-peek",
          "text": "A Quick Peek into Our Drug Interactions Shiny App"
        },
        {
          "href": "https://appsilon.com/exploring-drug-interactions-shiny-app/#pharmacokinetic",
          "text": "Pharmacokinetic Interactions"
        },
        {
          "href": "https://appsilon.com/exploring-drug-interactions-shiny-app/#pharmacodynamic",
          "text": "Pharmacodynamic Interactions"
        },
        {
          "href": "https://appsilon.com/exploring-drug-interactions-shiny-app/#summary",
          "text": "A Journey to Transform Life Sciences: Tapping into the Power of R/Shiny Technology"
        },
        {
          "href": "https://www.fda.gov/drugs/resources-drugs/drug-interactions-what-you-should-know",
          "text": "According to the FDA"
        },
        {
          "href": "https://demo.prod.appsilon.ai/drug-interaction/",
          "text": "Drug Interactions Shiny App"
        },
        {
          "href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429341/",
          "text": "scientific study"
        },
        {
          "href": "https://pubmed.ncbi.nlm.nih.gov/6777108/",
          "text": "scientific study"
        },
        {
          "href": "https://www.amjmed.com/article/0002-9343(88)90054-X/fulltext#:~:text=The%20interaction%20between%20phenytoin%20and,and%20the%20drug's%20pharmacologic%20effect.",
          "text": "This results in toxicity at concentrations usually considered to be within the therapeutic range"
        },
        {
          "href": "https://pubmed.ncbi.nlm.nih.gov/24381240/",
          "text": "case study"
        },
        {
          "href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250726/",
          "text": "scientific publication"
        },
        {
          "href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250726/",
          "text": "most clinically important"
        },
        {
          "href": "https://link.springer.com/article/10.1007/BF00278469",
          "text": "scientific research"
        },
        {
          "href": "https://pubmed.ncbi.nlm.nih.gov/2213774/",
          "text": "another study"
        },
        {
          "href": "https://www.frontiersin.org/articles/10.3389/fphar.2017.00158/full",
          "text": "Synergy"
        },
        {
          "href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529235/#:~:text=The%20definition%20of%20additivity%20is,individual%20agent%20in%20the%20combination.",
          "text": "additivity interaction"
        },
        {
          "href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444856/",
          "text": "antagonistic"
        },
        {
          "href": "https://www.sciencedirect.com/science/article/pii/S2213538322000613",
          "text": "requires further clinical investigation"
        },
        {
          "href": "https://www.cancer.gov/about-cancer/treatment/drugs/nivolumab",
          "text": "Nivolumab"
        },
        {
          "href": "https://www.cancer.gov/about-cancer/treatment/drugs/ipilimumab",
          "text": "Ipilimumab"
        },
        {
          "href": "https://www.jocmr.org/index.php/JOCMR/article/view/3750/25892848",
          "text": "immune-related adverse events"
        },
        {
          "href": "https://www.nature.com/articles/s41571-019-0218-0",
          "text": "incidence and severity of irAEs"
        },
        {
          "href": "https://www.sciencedirect.com/science/article/abs/pii/S1567576923002011",
          "text": "different times and locations throughout T cell evolution"
        },
        {
          "href": "https://journals.sagepub.com/doi/pdf/10.4103/jpp.jpp_16_21",
          "text": "commonly interacting combination"
        },
        {
          "href": "https://journals.sagepub.com/doi/pdf/10.4103/jpp.jpp_16_21",
          "text": "cell cycle-dependent antagonistic interactions"
        },
        {
          "href": "https://www.appsilon.bio/",
          "text": "R/Shiny as a transformative tool in the realm of Life Sciences"
        },
        {
          "href": "https://appsilon.com/#contact",
          "text": "Appsilon"
        },
        {
          "href": "https://appsilon.com/r-shiny-pharma-biotech-examples/",
          "text": "Expert Enterprise-Level R/Shiny Application Development"
        },
        {
          "href": "https://appsilon.com/exploring-drug-interactions-shiny-app/",
          "text": "Tag: r - Appsilon | Enterprise R Shiny Dashboards"
        },
        {
          "href": "https://feedburner.google.com/fb/a/mailverify?uri=RBloggers",
          "text": "daily e-mail updates"
        },
        {
          "href": "https://www.r-project.org/",
          "text": "R"
        },
        {
          "href": "https://www.r-users.com/",
          "text": "Click here if you're looking to post or find an R/data-science job"
        },
        {
          "href": "http://r-posts.com/",
          "text": "here"
        }
      ],
      "h1_title": "R-bloggers",
      "html_title": "Exploring Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions with our Drug Interactions Shiny App | R-bloggers",
      "images": [
        {
          "alt": null,
          "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
          "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
        },
        {
          "alt": null,
          "base64": null,
          "src": "https://wordpress.appsilon.com/wp-content/uploads/2023/11/drug_interactions-2.webp"
        },
        {
          "alt": "ðŸš¨",
          "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
          "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
        },
        {
          "alt": "ðŸš¨",
          "base64": null,
          "src": "https://i0.wp.com/s.w.org/images/core/emoji/14.0.0/72x72/1f6a8.png?w=578&ssl=1"
        },
        {
          "alt": "ðŸš¨",
          "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
          "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
        },
        {
          "alt": "ðŸš¨",
          "base64": null,
          "src": "https://i0.wp.com/s.w.org/images/core/emoji/14.0.0/72x72/1f6a8.png?w=578&ssl=1"
        },
        {
          "alt": null,
          "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
          "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
        },
        {
          "alt": "A",
          "base64": null,
          "src": "https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_10-49-02.webp"
        },
        {
          "alt": null,
          "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
          "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
        },
        {
          "alt": "The",
          "base64": null,
          "src": "https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_10-59-15.webp"
        },
        {
          "alt": "The dashboard indicating a drug interaction alert between two drugs: Ethinyl estradiol and Rifampin. The alert states that the metabolism of Ethinyl estradiol can be increased when combined with Rifampin.",
          "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
          "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
        },
        {
          "alt": "The dashboard indicating a drug interaction alert between two drugs: Ethinyl estradiol and Rifampin. The alert states that the metabolism of Ethinyl estradiol can be increased when combined with Rifampin.",
          "base64": null,
          "src": "https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_11-05-53.webp"
        },
        {
          "alt": "The dashboard states that the serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.",
          "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
          "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
        },
        {
          "alt": "The dashboard states that the serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.",
          "base64": null,
          "src": "https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_11-26-38.webp"
        },
        {
          "alt": "The dashboard shows a notification about a drug interaction, specifically stating that the risk or severity of adverse effects can be increased when Ipilimumab is combined with Nivolumab.",
          "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
          "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
        },
        {
          "alt": "The dashboard shows a notification about a drug interaction, specifically stating that the risk or severity of adverse effects can be increased when Ipilimumab is combined with Nivolumab.",
          "base64": null,
          "src": "https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_12-03-28.webp"
        },
        {
          "alt": "The dashboard shows the interaction between two drugs, Paclitaxel and Carboplatin. The alert warns that the risk or severity of adverse effects can be increased when Carboplatin is combined with Paclitaxel.",
          "base64": "data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7",
          "src": "https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif"
        },
        {
          "alt": "The dashboard shows the interaction between two drugs, Paclitaxel and Carboplatin. The alert warns that the risk or severity of adverse effects can be increased when Carboplatin is combined with Paclitaxel.",
          "base64": null,
          "src": "https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_12-19-27.webp"
        }
      ],
      "internal_links": [
        {
          "href": "https://www.r-bloggers.com/author/ismael-rodriguez/",
          "text": "Ismael Rodriguez"
        },
        {
          "href": "https://www.r-bloggers.com/category/r-bloggers/",
          "text": "R bloggers"
        },
        {
          "href": "https://www.r-bloggers.com/",
          "text": "R-bloggers"
        },
        {
          "href": "https://www.r-bloggers.com/contact-us/",
          "text": "here"
        },
        {
          "href": "https://www.r-bloggers.com/add-your-blog/",
          "text": "click here"
        },
        {
          "href": "https://www.r-bloggers.com/",
          "text": "R-bloggers.com"
        },
        {
          "href": "https://www.r-bloggers.com/how-to-learn-r-2/",
          "text": "learning R"
        },
        {
          "href": "https://www.r-bloggers.com/add-your-blog/",
          "text": "click here"
        }
      ],
      "lang": "en-US",
      "main_html": "<article class=\"post-379756 post type-post status-publish format-standard hentry category-r-bloggers\">\n<header class=\"post-header\">\n<h1 class=\"entry-title\">Exploring Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions with our Drug Interactions Shiny App</h1>\n<p class=\"meta post-meta\">Posted on <span class=\"updated\">November 7, 2023</span>  by <span class=\"vcard author\"><a class=\"fn\" href=\"https://www.r-bloggers.com/author/ismael-rodriguez/\">Ismael Rodriguez</a></span>  in <a href=\"https://www.r-bloggers.com/category/r-bloggers/\" rel=\"category tag\">R bloggers</a> | 0 Comments</p>\n</header>\n<div class=\"entry clearfix\">\n<!-- \r\n<div style=\"min-height: 30px;\">\r\n[social4i size=\"small\" align=\"align-left\"]\r\n</div>\r\n-->\n<div style=\"border: 1px solid; background: none repeat scroll 0 0 #EDEDED; margin: 1px; font-size: 12px;\">\r\n[This article was first published on  <strong><a href=\"https://appsilon.com/exploring-drug-interactions-shiny-app/\"> Tag: r - Appsilon | Enterprise R Shiny Dashboards</a></strong>, and kindly contributed to <a href=\"https://www.r-bloggers.com/\" rel=\"nofollow\">R-bloggers</a>].  (You can report issue about the content on this page <a href=\"https://www.r-bloggers.com/contact-us/\">here</a>)\r\n<hr/>Want to share your content on R-bloggers?<a href=\"https://www.r-bloggers.com/add-your-blog/\" rel=\"nofollow\"> click here</a> if you have a blog, or <a href=\"http://r-posts.com/\" rel=\"nofollow\"> here</a> if you don't.\r\n</div>\n\n<!-- Share buttons by mashshare.net - Version: 3.8.9--><div><img alt=\"\" class=\"attachment-medium size-medium wp-post-image\" data-lazy-src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/drug_interactions-2.webp\" decoding=\"async\" loading=\"lazy\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\" style=\"margin-bottom: 15px;\" width=\"450\"/><noscript><img alt=\"\" class=\"attachment-medium size-medium wp-post-image\" decoding=\"async\" loading=\"lazy\" src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/drug_interactions-2.webp\" style=\"margin-bottom: 15px;\" width=\"450\"/></noscript></div><p>In the field of <strong>oncology</strong>, in-depth research into and comprehension of <a href=\"https://appsilon.com/drug-drug-interactions-r-shiny/\" rel=\"nofollow\" target=\"_blank\">drug-drug interactions</a> hold paramount significance. This is especially crucial given the limited margin between the effective and toxic doses of anticancer agents.</p>\n<p>In this article, we discuss what drug interaction is, the different kinds, and take a look into some of these interactions through our <a href=\"https://demo.prod.appsilon.ai/drug-interaction/\" rel=\"nofollow\" target=\"_blank\">drug interactions Shiny app.</a></p>\n<h2 id=\"introduction\">What is a Drug Interaction?</h2>\n<p>Drug interactions are reactions between two (or more) drugs or between a drug and another element, such as food or supplements. Drug interactions are important because they can cause unwanted side effects. They can also increase or reduce the action of a particular drug.</p>\n<h2 id=\"important\"><img alt=\"ðŸš¨\" class=\"wp-smiley\" data-lazy-src=\"https://i0.wp.com/s.w.org/images/core/emoji/14.0.0/72x72/1f6a8.png?w=578&amp;ssl=1\" data-recalc-dims=\"1\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\" style=\"height: 1em; max-height: 1em;\"/><noscript><img alt=\"ðŸš¨\" class=\"wp-smiley\" data-recalc-dims=\"1\" src=\"https://i0.wp.com/s.w.org/images/core/emoji/14.0.0/72x72/1f6a8.png?w=578&amp;ssl=1\" style=\"height: 1em; max-height: 1em;\"/></noscript> Important Note</h2>\n<p>The text presented here does not represent medical advice. Always consult with your doctor in health-related matters. Our application purely presents data from the <a href=\"https://www.nlm.nih.gov/\" rel=\"nofollow\" target=\"_blank\">US National Library of Medicine and the National Institute of Health</a> datasets.</p>\n<h3>Table of Contents</h3>\n<ul>\n<li><a href=\"https://appsilon.com/exploring-drug-interactions-shiny-app/#introduction\" rel=\"nofollow\" target=\"_blank\">What is a Drug Interaction?</a></li>\n<li><a href=\"https://appsilon.com/exploring-drug-interactions-shiny-app/#important\" rel=\"nofollow\" target=\"_blank\"><img alt=\"ðŸš¨\" class=\"wp-smiley\" data-lazy-src=\"https://i0.wp.com/s.w.org/images/core/emoji/14.0.0/72x72/1f6a8.png?w=578&amp;ssl=1\" data-recalc-dims=\"1\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\" style=\"height: 1em; max-height: 1em;\"/><noscript><img alt=\"ðŸš¨\" class=\"wp-smiley\" data-recalc-dims=\"1\" src=\"https://i0.wp.com/s.w.org/images/core/emoji/14.0.0/72x72/1f6a8.png?w=578&amp;ssl=1\" style=\"height: 1em; max-height: 1em;\"/></noscript> Important Note</a></li>\n<li><a href=\"https://appsilon.com/exploring-drug-interactions-shiny-app/#drug-interactions\" rel=\"nofollow\" target=\"_blank\">What Kind of Drug Interactions Can Occur?</a></li>\n<li><a href=\"https://appsilon.com/exploring-drug-interactions-shiny-app/#quick-peek\" rel=\"nofollow\" target=\"_blank\">A Quick Peek into Our Drug Interactions Shiny App</a></li>\n<li><a href=\"https://appsilon.com/exploring-drug-interactions-shiny-app/#pharmacokinetic\" rel=\"nofollow\" target=\"_blank\">Pharmacokinetic Interactions</a></li>\n<li><a href=\"https://appsilon.com/exploring-drug-interactions-shiny-app/#pharmacodynamic\" rel=\"nofollow\" target=\"_blank\">Pharmacodynamic Interactions</a></li>\n<li><a href=\"https://appsilon.com/exploring-drug-interactions-shiny-app/#summary\" rel=\"nofollow\" target=\"_blank\">A Journey to Transform Life Sciences: Tapping into the Power of R/Shiny Technology</a></li>\n</ul>\n<h2 id=\"drug-interactions\">What Kind of Drug Interactions Can Occur?</h2>\n<p><a href=\"https://www.fda.gov/drugs/resources-drugs/drug-interactions-what-you-should-know\" rel=\"nofollow\" target=\"_blank\">According to the FDA</a>, these types of interactions fall into three categories:</p>\n<ul>\n<li><strong>Drug-drug interactions:</strong> This happens when two or more drugs interact with each other.</li>\n<li><strong>Drug-food/beverage interaction:</strong> This is the result of a drug reacting with food or beverages.</li>\n<li><strong>Drug-condition interaction: </strong>This type occurs when a pre-existing medical condition makes a particular drug potentially harmful.</li>\n</ul>\n<p>Drugs can interact at two levels: <strong>pharmacokinetic</strong> and <strong>pharmacodynamic</strong>.</p>\n<p>We will explore a few important drug interactions and will analyze them using our <strong><a href=\"https://demo.prod.appsilon.ai/drug-interaction/\" rel=\"nofollow\" target=\"_blank\">Drug Interactions Shiny App</a></strong>.</p>\n<h3 id=\"quick-peek\">A Quick Peek into Our Drug Interactions Shiny App</h3>\n<p>The app fundamentally simplifies information access by removing the intricacy of navigating various databases and sorting through pertinent data. Additionally, the secondary drug search box displays any high-severity interactions that may be present.</p>\n<p></p>\n<h2 id=\"pharmacokinetic\">Pharmacokinetic Interactions</h2>\n<p>When an interaction at the <strong>pharmacokinetic</strong> level occurs, it means that a drug alters how the other is absorbed, distributed, metabolized or excreted; this results in an increased or decreased drug concentration in the body that is available to produce a pharmacological effect.</p>\n<h3 id=\"absorption\">Absorption interactions</h3>\n<h4 id=\"warchol\">Warfarin and Cholestyramine</h4>\n<div class=\"wp-caption aligncenter\" id=\"attachment_21549\" style=\"width: 1162px\"><img aria-describedby=\"caption-attachment-21549\" class=\"size-full wp-image-21549\" data-lazy-src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_10-49-02.webp\" data4good=\"\" decoding=\"async\" interactions=\"\" loading=\"lazy\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\" width=\"450\"/><noscript><img a=\"\" absorption,=\"\" alerts=\"\" alt=\"A \" and=\"\" aria-describedby=\"caption-attachment-21549\" between=\"\" can=\"\" cholestyramine=\"\" class=\"size-full wp-image-21549\" concentration=\"\" dashboard=\"\" dashboard\"=\"\" data4good=\"\" decoding=\"async\" decreasing=\"\" drug=\"\" efficacy.\"=\"\" focus=\"\" interaction=\"\" interactions=\"\" its=\"\" loading=\"lazy\" on=\"\" reduce=\"\" resin.=\"\" serum=\"\" src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_10-49-02.webp\" that=\"\" the=\"\" warfarin=\"\" width=\"450\" with=\"\"/></noscript><p class=\"wp-caption-text\" id=\"caption-attachment-21549\">Drug Interactions Dashboard: Warfarin and Cholestyramine</p></div>\n<p>The information that we got from analyzing this interaction in our app is the following: cholestyramine may cause a decrease in the absorption of Warfarin, resulting in a reduced serum concentration and potentially a decrease in efficacy.</p>\n<h5>Mechanism of Interaction</h5>\n<p>According to a <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429341/\" rel=\"nofollow\" target=\"_blank\">scientific study</a>, cholestyramine treatment (4g three times daily) decreased the biological half-life of plasma warfarin and increased the total clearance of this drug. Also, the total anticoagulant effect per dose of warfarin, measured by the area under the effect v time curve, was also reduced by 25 % when cholestyramine was administered.</p>\n<h3 id=\"distribution\">Distribution Interactions</h3>\n<h4 id=\"phenval\">Phenytoin and Valproic Acid</h4>\n<div class=\"wp-caption aligncenter\" id=\"attachment_21551\" style=\"width: 1128px\"><img aria-describedby=\"caption-attachment-21551\" class=\"size-full wp-image-21551\" data-lazy-src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_10-59-15.webp\" data4good=\"\" decoding=\"async\" interactions=\"\" loading=\"lazy\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\" width=\"450\"/><noscript><img a=\"\" acid.\"=\"\" alt=\"The \" aria-describedby=\"caption-attachment-21551\" be=\"\" can=\"\" class=\"size-full wp-image-21551\" combined=\"\" concentration=\"\" dashboard,\"=\"\" data4good=\"\" decoding=\"async\" decreased=\"\" drug=\"\" indicating=\"\" interaction=\"\" interactions=\"\" loading=\"lazy\" of=\"\" phenytoin=\"\" serum=\"\" src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_10-59-15.webp\" that=\"\" the=\"\" valproic=\"\" warning=\"\" when=\"\" width=\"450\" with=\"\"/></noscript><p class=\"wp-caption-text\" id=\"caption-attachment-21551\">Drug Interactions Dashboard: Phenytoin and Valproic acid</p></div>\n<p>Once we select these two drugs in our application, the following drug interaction is displayed: the serum concentration of Phenytoin can be decreased when it is combined with Valproic acid.</p>\n<h5>Mechanism of interaction</h5>\n<p>In a <a href=\"https://pubmed.ncbi.nlm.nih.gov/6777108/\" rel=\"nofollow\" target=\"_blank\">scientific study</a>, the effect of sodium valproate on the disposition kinetics of intravenous phenytoin was investigated in a group of normal subjects. They found that after valproate, the free (unbound) fraction of phenytoin in serum rose from 9.6 % to 15.6 % on average (p &lt; 0.001). The free phenytoin concentration in serum and phenytoin concentration in saliva increased during valproate administration.</p>\n<p>The researchersâ€™ results suggested that valproic acid administration may have two separate and opposing effects on phenytoin disposition:</p>\n<ol>\n<li>Displacing phenytoin from plasma protein binding sites, thus enhancing the systemic clearance of the total drug.</li>\n<li>Inhibition of phenytoin metabolism, thus increasing the concentration of free drug in the serum.</li>\n</ol>\n<p>This interaction, which results in an increase in the free fraction of phenytoin, alters the relationship between total phenytoin concentration and the drugâ€™s pharmacological effect. <a href=\"https://www.amjmed.com/article/0002-9343(88)90054-X/fulltext#:~:text=The%20interaction%20between%20phenytoin%20and,and%20the%20drug's%20pharmacologic%20effect.\" rel=\"nofollow\" target=\"_blank\">This results in toxicity at concentrations usually considered to be within the therapeutic range</a>.</p>\n<p>A <a href=\"https://pubmed.ncbi.nlm.nih.gov/24381240/\" rel=\"nofollow\" target=\"_blank\">case study</a> showcasing the clinical outcomes of this interaction was reported. In this case study, the patient presented phenytoin toxicity despite receiving the appropriate administration of phenytoin.</p>\n<h3 id=\"metabolism\">Metabolism Interactions</h3>\n<h4 id=\"ethri\">Ethinylestradiol and Rifampin</h4>\n<div class=\"wp-caption aligncenter\" id=\"attachment_21553\" style=\"width: 1128px\"><img alt=\"The dashboard indicating a drug interaction alert between two drugs: Ethinyl estradiol and Rifampin. The alert states that the metabolism of Ethinyl estradiol can be increased when combined with Rifampin. \" aria-describedby=\"caption-attachment-21553\" class=\"wp-image-21553 size-full\" data-lazy-src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_11-05-53.webp\" decoding=\"async\" loading=\"lazy\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\" width=\"450\"/><noscript><img alt=\"The dashboard indicating a drug interaction alert between two drugs: Ethinyl estradiol and Rifampin. The alert states that the metabolism of Ethinyl estradiol can be increased when combined with Rifampin. \" aria-describedby=\"caption-attachment-21553\" class=\"wp-image-21553 size-full\" decoding=\"async\" loading=\"lazy\" src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_11-05-53.webp\" width=\"450\"/></noscript><p class=\"wp-caption-text\" id=\"caption-attachment-21553\">Drug Interactions Dashboard: Ethinyl estradiol and Rifampin</p></div>\n<p>Our application shows one interaction: the metabolism of Ethinylestradiol can be increased when combined with Rifampin.</p>\n<h5>Mechanism of Interaction</h5>\n<p>According to a <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250726/\" rel=\"nofollow\" target=\"_blank\">scientific publication</a>, ethinylestradiol is the most common estrogen found in oral contraceptive preparations. The main metabolic pathway of this estrogen is hydroxylation (by the cytochrome P450 IIIA4 or CYP3A4), and a minor pathway is conjugation, which results in sulphation or glucuronidation of the original steroid. The resulting conjugates reach the small intestine, where hydrolytic enzymes of intestinal bacteria break them down, which results in the release of active estrogenic hormone.</p>\n<p>Antibiotics could diminish the efficacy of oral contraceptives, such as ethinylestradiol, by two main mechanisms:</p>\n<ol>\n<li>By interfering with the enterohepatic cycling of ethinylestradiol.</li>\n<li>By inducing a group of hepatic microsomal enzymes of the cytochrome P450.</li>\n</ol>\n<p>The former is considered to be the <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250726/\" rel=\"nofollow\" target=\"_blank\">most clinically important</a>. Rifampin induces enzymes of the cytochrome P450 in the liver, which results in an increased hepatic hydroxylation of estrogens by fourfold. This results in both a reduction in the area under the curve (AUC) and increased clearance.</p>\n<h3 id=\"excretion\">Excretion Interactions</h3>\n<h4 id=\"methibu\">Methotrexate and Ibuprofen</h4>\n<div class=\"wp-caption aligncenter\" id=\"attachment_21556\" style=\"width: 1126px\"><img alt=\"The dashboard states that the serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.\" aria-describedby=\"caption-attachment-21556\" class=\"wp-image-21556 size-full\" data-lazy-src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_11-26-38.webp\" decoding=\"async\" loading=\"lazy\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\" width=\"450\"/><noscript><img alt=\"The dashboard states that the serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.\" aria-describedby=\"caption-attachment-21556\" class=\"wp-image-21556 size-full\" decoding=\"async\" loading=\"lazy\" src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_11-26-38.webp\" width=\"450\"/></noscript><p class=\"wp-caption-text\" id=\"caption-attachment-21556\">Drug Interactions: Methotrexate and Ibuprofen</p></div>\n<p>By using our application to analyze possible interactions between these two drugs, we can observe the following: the serum concentration of methotrexate can be increased when it is combined with ibuprofen.</p>\n<h5>Mechanism of Interaction</h5>\n<p>Common over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) include: aspirin, ibuprofen and naproxen sodium. Several NSAIDs, including ibuprofen, have been shown to reduce renal clearance of methotrexate, which could lead to toxicity (i.e., renal failure), when methotrexate is administered at high doses.</p>\n<p>A <a href=\"https://link.springer.com/article/10.1007/BF00278469\" rel=\"nofollow\" target=\"_blank\">scientific research</a> investigated the pharmacokinetics of methotrexate in patients with rheumatoid arthritis concurrently treated with NSAIDs. They found that the apparent systemic clearance of methotrexate was significantly reduced by the treatment with NSAIDs, including ibuprofen. Ibuprofen significantly reduced methotrexate renal clearance. This data showed that NSAIDs can affect the disposition of methotrexate and increase its toxicity.</p>\n<p>In <a href=\"https://pubmed.ncbi.nlm.nih.gov/2213774/\" rel=\"nofollow\" target=\"_blank\">another study</a>, the findings indicated that there is a lack of significant interaction between low-dose methotrexate and ibuprofen in patients with arthritis when using up to 25 mg/dose and 2400 mg/day of ibuprofen.</p>\n<p>The results of these studies show that for some drug interactions, itâ€™s really important to consider the doses being administered or studied.</p>\n<h2 id=\"pharmacodynamic\">Pharmacodynamic Interactions</h2>\n<p>This type of interaction occurs when two or more administered drugs have similar or antagonistic pharmacological properties.</p>\n<p>When two or more drugs have similar mechanisms of action, their interaction is known as additive or synergistic.</p>\n<p><a href=\"https://www.frontiersin.org/articles/10.3389/fphar.2017.00158/full\" rel=\"nofollow\" target=\"_blank\">Synergy</a> is commonly defined as the effect of two or more agents working in combination that is greater than the expected additive effect of said agents.</p>\n<p>An <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529235/#:~:text=The%20definition%20of%20additivity%20is,individual%20agent%20in%20the%20combination.\" rel=\"nofollow\" target=\"_blank\">additivity interaction</a> occurs when the overall effect caused by a drug combination is the sum of the pharmacological effects of each individual agent in the combination.</p>\n<p>When two or more drugs have antagonistic properties, these drugs compete to interact with their targeted receptor. This type of interaction is known as antagonistic interaction. When the effect of one drug is impeded by another, the effects of these drugs are <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444856/\" rel=\"nofollow\" target=\"_blank\">antagonistic</a>.</p>\n<h3 id=\"possible\">A Possible Synergistic or Additive interaction</h3>\n<h4 id=\"nivoipil\">Nivolumab and Ipilimumab</h4>\n<div class=\"wp-caption aligncenter\" id=\"attachment_21561\" style=\"width: 1119px\"><img alt=\"The dashboard shows a notification about a drug interaction, specifically stating that the risk or severity of adverse effects can be increased when Ipilimumab is combined with Nivolumab.\" aria-describedby=\"caption-attachment-21561\" class=\"wp-image-21561 size-full\" data-lazy-src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_12-03-28.webp\" decoding=\"async\" loading=\"lazy\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\" width=\"450\"/><noscript><img alt=\"The dashboard shows a notification about a drug interaction, specifically stating that the risk or severity of adverse effects can be increased when Ipilimumab is combined with Nivolumab.\" aria-describedby=\"caption-attachment-21561\" class=\"wp-image-21561 size-full\" decoding=\"async\" loading=\"lazy\" src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_12-03-28.webp\" width=\"450\"/></noscript><p class=\"wp-caption-text\" id=\"caption-attachment-21561\">Drug Interactions Dashboard: Nivolumab and Ipilimumab</p></div>\n<p>Our Shiny application shows that the risk or severity of adverse effects can be increased when Ipilimumab is combined with Nivolumab. Cancer immunotherapy has demonstrated great clinical success. Whether a combination of multiple inhibitors provides a synergistic or additive effect <a href=\"https://www.sciencedirect.com/science/article/pii/S2213538322000613\" rel=\"nofollow\" target=\"_blank\">requires further clinical investigation</a>.</p>\n<h5>Adverse Events â€“ Mechanism of Interaction</h5>\n<p><a href=\"https://www.cancer.gov/about-cancer/treatment/drugs/nivolumab\" rel=\"nofollow\" target=\"_blank\"><strong>Nivolumab</strong></a> is a type of targeted therapy drug called an immune checkpoint inhibitor (ICI) (a type of immunotherapy). It is a monoclonal antibody that binds to the protein programmed death 1 <strong>(PD-1)</strong> on the surface of T cells. It works by keeping cancer cells from suppressing the immune system. This allows the immune system to attack and kill the cancer cells.</p>\n<p><strong><a href=\"https://www.cancer.gov/about-cancer/treatment/drugs/ipilimumab\" rel=\"nofollow\" target=\"_blank\">Ipilimumab</a></strong> is also an immune checkpoint inhibitor. It is a monoclonal antibody that binds to the protein cytotoxic T-lymphocyte-associated antigen 4 <strong>(CTLA-4)</strong> on T cells. It also prevents cancer cells from suppressing the immune system.</p>\n<p>The occurrence of serious adverse events seen during the treatment with immune checkpoint inhibitors are related to excessive immune activation, something collectively known as <a href=\"https://www.jocmr.org/index.php/JOCMR/article/view/3750/25892848\" rel=\"nofollow\" target=\"_blank\">immune-related adverse events</a> (irAEs). The combination of anti-CTLA-4 antibody and anti-PD-1 antibody increases both the <a href=\"https://www.nature.com/articles/s41571-019-0218-0\" rel=\"nofollow\" target=\"_blank\">incidence and severity of irAEs</a>. The mechanism of ICI- induced irAEs varies according to the affected organ.</p>\n<h5>Synergistic or Additive effect â€“ Possible Mechanism of Interaction</h5>\n<p>PD-1 inhibitors (such as Nivolumab) affect T cell inflammation in inflamed tissues (i.e., in the tumor microenvironment). CTLA-4 inhibitors target T cells at sites of priming (i.e., tumor draining lymph nodes). Due to the distinct mechanisms of action, the combination of these two ICIs can boost anticancer immune response at <a href=\"https://www.sciencedirect.com/science/article/abs/pii/S1567576923002011\" rel=\"nofollow\" target=\"_blank\">different times and locations throughout T cell evolution</a>.</p>\n<h3 id=\"antagonistic\">Antagonistic Interaction</h3>\n<h4 id=\"paclcarb\">Paclitaxel with Carboplatin</h4>\n<div class=\"wp-caption aligncenter\" id=\"attachment_21563\" style=\"width: 1109px\"><img alt=\"The dashboard shows the interaction between two drugs, Paclitaxel and Carboplatin. The alert warns that the risk or severity of adverse effects can be increased when Carboplatin is combined with Paclitaxel.\" aria-describedby=\"caption-attachment-21563\" class=\"wp-image-21563 size-full\" data-lazy-src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_12-19-27.webp\" decoding=\"async\" loading=\"lazy\" src=\"https://www.r-bloggers.com/wp-content/plugins/jetpack/modules/lazy-images/images/1x1.trans.gif\" width=\"450\"/><noscript><img alt=\"The dashboard shows the interaction between two drugs, Paclitaxel and Carboplatin. The alert warns that the risk or severity of adverse effects can be increased when Carboplatin is combined with Paclitaxel.\" aria-describedby=\"caption-attachment-21563\" class=\"wp-image-21563 size-full\" decoding=\"async\" loading=\"lazy\" src=\"https://wordpress.appsilon.com/wp-content/uploads/2023/11/image_2023-11-07_12-19-27.webp\" width=\"450\"/></noscript><p class=\"wp-caption-text\" id=\"caption-attachment-21563\">Drug Interactions Dashboard: Paclitaxel with Carboplatin</p></div>\n<p>The application shows the following: The risk or severity of adverse effects can be increased when Carboplatin is combined with Paclitaxel.</p>\n<p>This is a <a href=\"https://journals.sagepub.com/doi/pdf/10.4103/jpp.jpp_16_21\" rel=\"nofollow\" target=\"_blank\">commonly interacting combination</a> among chemotherapeutic drugs; this combination is commonly used for treating multiple solid tumours.</p>\n<h5>Mechanism of Interaction</h5>\n<p>The interaction effect is mainly due to <a href=\"https://journals.sagepub.com/doi/pdf/10.4103/jpp.jpp_16_21\" rel=\"nofollow\" target=\"_blank\">cell cycle-dependent antagonistic interactions</a>. The mechanism is that pretreatment or co-treatment of Carboplatin inhibits the paclitaxel-induced I-kappa B-alpha degradation and bcl-2 phosphorylation. Also, Paclitaxelâ€™s cytotoxic effects on both mitotic arrest and apoptotic cell death could interfere with carboplatin administration.</p>\n<h2 id=\"summary\">A Journey to Transform Life Sciences: Tapping into the Power of R/Shiny Technology</h2>\n<p>In conclusion, our journey through pharmacokinetic and pharmacodynamic drug-drug interactions has been incredibly illuminating, thanks to the power of our Drug Interactions Shiny App.</p>\n<p>At Appsilon, we recognize the immense potential of <a href=\"https://www.appsilon.bio/\" rel=\"nofollow\" target=\"_blank\">R/Shiny as a transformative tool in the realm of Life Sciences</a>. By leveraging its capabilities, we stand at the forefront of advancing discoveries in this field.</p>\n<p>R/Shiny allows us to create intuitive, interactive, and user-friendly interfaces, allowing researchers and professionals to delve deep into complex data effortlessly. Its flexibility enables us to adapt swiftly to evolving research needs, fostering a dynamic environment for discovery and innovation.</p>\n<p>Bring <a href=\"https://appsilon.com/#contact\" rel=\"nofollow\" target=\"_blank\">Appsilon</a> on board for <a href=\"https://appsilon.com/r-shiny-pharma-biotech-examples/\" rel=\"nofollow\" target=\"_blank\">Expert Enterprise-Level R/Shiny Application Development</a>.</p>\n<p>The post appeared first on appsilon.com/blog/.</p>\n<div class=\"jp-relatedposts\" id=\"jp-relatedposts\">\n<h3 class=\"jp-relatedposts-headline\"><em>Related</em></h3>\n</div>\n<!-- Share buttons by mashshare.net - Version: 3.8.9-->\n<div style=\"border: 1px solid; background: none repeat scroll 0 0 #EDEDED; margin: 1px; font-size: 13px;\">\n<div style=\"text-align: center;\">To <strong>leave a comment</strong> for the author, please follow the link and comment on their blog: <strong><a href=\"https://appsilon.com/exploring-drug-interactions-shiny-app/\"> Tag: r - Appsilon | Enterprise R Shiny Dashboards</a></strong>.</div>\n<hr>\n<a href=\"https://www.r-bloggers.com/\" rel=\"nofollow\">R-bloggers.com</a> offers <strong><a href=\"https://feedburner.google.com/fb/a/mailverify?uri=RBloggers\" rel=\"nofollow\">daily e-mail updates</a></strong> about <a href=\"https://www.r-project.org/\" rel=\"nofollow\" title=\"The R Project for Statistical Computing\">R</a> news and tutorials about <a href=\"https://www.r-bloggers.com/how-to-learn-r-2/\" rel=\"nofollow\" title=\"R tutorials\">learning R</a> and many other topics. <a href=\"https://www.r-users.com/\" rel=\"nofollow\" title=\"Data science jobs\">Click here if you're looking to post or find an R/data-science job</a>.\r\n\r\n<hr/>Want to share your content on R-bloggers?<a href=\"https://www.r-bloggers.com/add-your-blog/\" rel=\"nofollow\"> click here</a> if you have a blog, or <a href=\"http://r-posts.com/\" rel=\"nofollow\"> here</a> if you don't.\r\n</hr></div> </div>\n</article>",
      "main_text": "Exploring Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions with our Drug Interactions Shiny App\nPosted on\nNovember 7, 2023\nby\nIsmael Rodriguez\nin\nR bloggers\n| 0 Comments\n[This article was first published on\nTag: r - Appsilon | Enterprise R Shiny Dashboards\n, and kindly contributed to\nR-bloggers\n].  (You can report issue about the content on this page\nhere\n)\nWant to share your content on R-bloggers?\nclick here\nif you have a blog, or\nhere\nif you don't.\nIn the field of\noncology\n, in-depth research into and comprehension of\ndrug-drug interactions\nhold paramount significance. This is especially crucial given the limited margin between the effective and toxic doses of anticancer agents.\nIn this article, we discuss what drug interaction is, the different kinds, and take a look into some of these interactions through our\ndrug interactions Shiny app.\nWhat is a Drug Interaction?\nDrug interactions are reactions between two (or more) drugs or between a drug and another element, such as food or supplements. Drug interactions are important because they can cause unwanted side effects. They can also increase or reduce the action of a particular drug.\nImportant Note\nThe text presented here does not represent medical advice. Always consult with your doctor in health-related matters. Our application purely presents data from the\nUS National Library of Medicine and the National Institute of Health\ndatasets.\nTable of Contents\nWhat is a Drug Interaction?\nImportant Note\nWhat Kind of Drug Interactions Can Occur?\nA Quick Peek into Our Drug Interactions Shiny App\nPharmacokinetic Interactions\nPharmacodynamic Interactions\nA Journey to Transform Life Sciences: Tapping into the Power of R/Shiny Technology\nWhat Kind of Drug Interactions Can Occur?\nAccording to the FDA\n, these types of interactions fall into three categories:\nDrug-drug interactions:\nThis happens when two or more drugs interact with each other.\nDrug-food/beverage interaction:\nThis is the result of a drug reacting with food or beverages.\nDrug-condition interaction:\nThis type occurs when a pre-existing medical condition makes a particular drug potentially harmful.\nDrugs can interact at two levels:\npharmacokinetic\nand\npharmacodynamic\n.\nWe will explore a few important drug interactions and will analyze them using our\nDrug Interactions Shiny App\n.\nA Quick Peek into Our Drug Interactions Shiny App\nThe app fundamentally simplifies information access by removing the intricacy of navigating various databases and sorting through pertinent data. Additionally, the secondary drug search box displays any high-severity interactions that may be present.\nPharmacokinetic Interactions\nWhen an interaction at the\npharmacokinetic\nlevel occurs, it means that a drug alters how the other is absorbed, distributed, metabolized or excreted; this results in an increased or decreased drug concentration in the body that is available to produce a pharmacological effect.\nAbsorption interactions\nWarfarin and Cholestyramine\nDrug Interactions Dashboard: Warfarin and Cholestyramine\nThe information that we got from analyzing this interaction in our app is the following: cholestyramine may cause a decrease in the absorption of Warfarin, resulting in a reduced serum concentration and potentially a decrease in efficacy.\nMechanism of Interaction\nAccording to a\nscientific study\n, cholestyramine treatment (4g three times daily) decreased the biological half-life of plasma warfarin and increased the total clearance of this drug. Also, the total anticoagulant effect per dose of warfarin, measured by the area under the effect v time curve, was also reduced by 25 % when cholestyramine was administered.\nDistribution Interactions\nPhenytoin and Valproic Acid\nDrug Interactions Dashboard: Phenytoin and Valproic acid\nOnce we select these two drugs in our application, the following drug interaction is displayed: the serum concentration of Phenytoin can be decreased when it is combined with Valproic acid.\nMechanism of interaction\nIn a\nscientific study\n, the effect of sodium valproate on the disposition kinetics of intravenous phenytoin was investigated in a group of normal subjects. They found that after valproate, the free (unbound) fraction of phenytoin in serum rose from 9.6 % to 15.6 % on average (p < 0.001). The free phenytoin concentration in serum and phenytoin concentration in saliva increased during valproate administration.\nThe researchersâ€™ results suggested that valproic acid administration may have two separate and opposing effects on phenytoin disposition:\nDisplacing phenytoin from plasma protein binding sites, thus enhancing the systemic clearance of the total drug.\nInhibition of phenytoin metabolism, thus increasing the concentration of free drug in the serum.\nThis interaction, which results in an increase in the free fraction of phenytoin, alters the relationship between total phenytoin concentration and the drugâ€™s pharmacological effect.\nThis results in toxicity at concentrations usually considered to be within the therapeutic range\n.\nA\ncase study\nshowcasing the clinical outcomes of this interaction was reported. In this case study, the patient presented phenytoin toxicity despite receiving the appropriate administration of phenytoin.\nMetabolism Interactions\nEthinylestradiol and Rifampin\nDrug Interactions Dashboard: Ethinyl estradiol and Rifampin\nOur application shows one interaction: the metabolism of Ethinylestradiol can be increased when combined with Rifampin.\nMechanism of Interaction\nAccording to a\nscientific publication\n, ethinylestradiol is the most common estrogen found in oral contraceptive preparations. The main metabolic pathway of this estrogen is hydroxylation (by the cytochrome P450 IIIA4 or CYP3A4), and a minor pathway is conjugation, which results in sulphation or glucuronidation of the original steroid. The resulting conjugates reach the small intestine, where hydrolytic enzymes of intestinal bacteria break them down, which results in the release of active estrogenic hormone.\nAntibiotics could diminish the efficacy of oral contraceptives, such as ethinylestradiol, by two main mechanisms:\nBy interfering with the enterohepatic cycling of ethinylestradiol.\nBy inducing a group of hepatic microsomal enzymes of the cytochrome P450.\nThe former is considered to be the\nmost clinically important\n. Rifampin induces enzymes of the cytochrome P450 in the liver, which results in an increased hepatic hydroxylation of estrogens by fourfold. This results in both a reduction in the area under the curve (AUC) and increased clearance.\nExcretion Interactions\nMethotrexate and Ibuprofen\nDrug Interactions: Methotrexate and Ibuprofen\nBy using our application to analyze possible interactions between these two drugs, we can observe the following: the serum concentration of methotrexate can be increased when it is combined with ibuprofen.\nMechanism of Interaction\nCommon over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) include: aspirin, ibuprofen and naproxen sodium. Several NSAIDs, including ibuprofen, have been shown to reduce renal clearance of methotrexate, which could lead to toxicity (i.e., renal failure), when methotrexate is administered at high doses.\nA\nscientific research\ninvestigated the pharmacokinetics of methotrexate in patients with rheumatoid arthritis concurrently treated with NSAIDs. They found that the apparent systemic clearance of methotrexate was significantly reduced by the treatment with NSAIDs, including ibuprofen. Ibuprofen significantly reduced methotrexate renal clearance. This data showed that NSAIDs can affect the disposition of methotrexate and increase its toxicity.\nIn\nanother study\n, the findings indicated that there is a lack of significant interaction between low-dose methotrexate and ibuprofen in patients with arthritis when using up to 25 mg/dose and 2400 mg/day of ibuprofen.\nThe results of these studies show that for some drug interactions, itâ€™s really important to consider the doses being administered or studied.\nPharmacodynamic Interactions\nThis type of interaction occurs when two or more administered drugs have similar or antagonistic pharmacological properties.\nWhen two or more drugs have similar mechanisms of action, their interaction is known as additive or synergistic.\nSynergy\nis commonly defined as the effect of two or more agents working in combination that is greater than the expected additive effect of said agents.\nAn\nadditivity interaction\noccurs when the overall effect caused by a drug combination is the sum of the pharmacological effects of each individual agent in the combination.\nWhen two or more drugs have antagonistic properties, these drugs compete to interact with their targeted receptor. This type of interaction is known as antagonistic interaction. When the effect of one drug is impeded by another, the effects of these drugs are\nantagonistic\n.\nA Possible Synergistic or Additive interaction\nNivolumab and Ipilimumab\nDrug Interactions Dashboard: Nivolumab and Ipilimumab\nOur Shiny application shows that the risk or severity of adverse effects can be increased when Ipilimumab is combined with Nivolumab. Cancer immunotherapy has demonstrated great clinical success. Whether a combination of multiple inhibitors provides a synergistic or additive effect\nrequires further clinical investigation\n.\nAdverse Events â€“ Mechanism of Interaction\nNivolumab\nis a type of targeted therapy drug called an immune checkpoint inhibitor (ICI) (a type of immunotherapy). It is a monoclonal antibody that binds to the protein programmed death 1\n(PD-1)\non the surface of T cells. It works by keeping cancer cells from suppressing the immune system. This allows the immune system to attack and kill the cancer cells.\nIpilimumab\nis also an immune checkpoint inhibitor. It is a monoclonal antibody that binds to the protein cytotoxic T-lymphocyte-associated antigen 4\n(CTLA-4)\non T cells. It also prevents cancer cells from suppressing the immune system.\nThe occurrence of serious adverse events seen during the treatment with immune checkpoint inhibitors are related to excessive immune activation, something collectively known as\nimmune-related adverse events\n(irAEs). The combination of anti-CTLA-4 antibody and anti-PD-1 antibody increases both the\nincidence and severity of irAEs\n. The mechanism of ICI- induced irAEs varies according to the affected organ.\nSynergistic or Additive effect â€“ Possible Mechanism of Interaction\nPD-1 inhibitors (such as Nivolumab) affect T cell inflammation in inflamed tissues (i.e., in the tumor microenvironment). CTLA-4 inhibitors target T cells at sites of priming (i.e., tumor draining lymph nodes). Due to the distinct mechanisms of action, the combination of these two ICIs can boost anticancer immune response at\ndifferent times and locations throughout T cell evolution\n.\nAntagonistic Interaction\nPaclitaxel with Carboplatin\nDrug Interactions Dashboard: Paclitaxel with Carboplatin\nThe application shows the following: The risk or severity of adverse effects can be increased when Carboplatin is combined with Paclitaxel.\nThis is a\ncommonly interacting combination\namong chemotherapeutic drugs; this combination is commonly used for treating multiple solid tumours.\nMechanism of Interaction\nThe interaction effect is mainly due to\ncell cycle-dependent antagonistic interactions\n. The mechanism is that pretreatment or co-treatment of Carboplatin inhibits the paclitaxel-induced I-kappa B-alpha degradation and bcl-2 phosphorylation. Also, Paclitaxelâ€™s cytotoxic effects on both mitotic arrest and apoptotic cell death could interfere with carboplatin administration.\nA Journey to Transform Life Sciences: Tapping into the Power of R/Shiny Technology\nIn conclusion, our journey through pharmacokinetic and pharmacodynamic drug-drug interactions has been incredibly illuminating, thanks to the power of our Drug Interactions Shiny App.\nAt Appsilon, we recognize the immense potential of\nR/Shiny as a transformative tool in the realm of Life Sciences\n. By leveraging its capabilities, we stand at the forefront of advancing discoveries in this field.\nR/Shiny allows us to create intuitive, interactive, and user-friendly interfaces, allowing researchers and professionals to delve deep into complex data effortlessly. Its flexibility enables us to adapt swiftly to evolving research needs, fostering a dynamic environment for discovery and innovation.\nBring\nAppsilon\non board for\nExpert Enterprise-Level R/Shiny Application Development\n.\nThe post appeared first on appsilon.com/blog/.\nRelated\nTo\nleave a comment\nfor the author, please follow the link and comment on their blog:\nTag: r - Appsilon | Enterprise R Shiny Dashboards\n.\nR-bloggers.com\noffers\ndaily e-mail updates\nabout\nR\nnews and tutorials about\nlearning R\nand many other topics.\nClick here if you're looking to post or find an R/data-science job\n.\nWant to share your content on R-bloggers?\nclick here\nif you have a blog, or\nhere\nif you don't.",
      "meta_description": "In the field of oncology, in-depth research into and comprehension of drug-drug interactions hold paramount significance. This is especially crucial given the limited margin between the effective and toxic doses of anticancer agents. In this article, we discuss what drug interaction is, the different kinds, and take a look into some of these interactions through [â€¦] The post appeared first on appsilon.com/blog/.",
      "meta_keywords": null,
      "og_description": "In the field of oncology, in-depth research into and comprehension of drug-drug interactions hold paramount significance. This is especially crucial given the limited margin between the effective and toxic doses of anticancer agents. In this article, we discuss what drug interaction is, the different kinds, and take a look into some of these interactions through [â€¦] The post appeared first on appsilon.com/blog/.",
      "og_image": "https://wordpress.appsilon.com/wp-content/uploads/2023/11/drug_interactions-2.webp",
      "og_title": "Exploring Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions with our Drug Interactions Shiny App | R-bloggers",
      "raw_jsonld_article": null,
      "reading_time_min": 9.6,
      "sitemap_lastmod": "2023-11-07T12:45:24+00:00",
      "twitter_description": "In the field of oncology, in-depth research into and comprehension of drug-drug interactions hold paramount significance. This is especially crucial given the limited margin between the effective and toxic doses of anticancer agents. In this article, we discuss what drug interaction is, the different kinds, and take a look into some of these interactions through [â€¦] The post appeared first on appsilon.com/blog/.",
      "twitter_title": "Exploring Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions with our Drug Interactions Shiny App | R-bloggers",
      "url": "https://www.r-bloggers.com/2023/11/exploring-pharmacokinetic-and-pharmacodynamic-drug-drug-interactions-with-our-drug-interactions-shiny-app/",
      "word_count": 1927
    }
  }
}